Scotiabank Maintains Sector Outperform on Bio-Techne, Raises Price Target to $88

Bio-Techne Corporation

Bio-Techne Corporation

TECH

0.00

Scotiabank analyst Sung Ji Nam maintains Bio-Techne (NASDAQ: TECH) with a Sector Outperform and raises the price target from $83 to $88.